Alvotech (ALVO) Change in Accured Expenses (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Accured Expenses came in at -$948000.0 in Q1 2026, up 74.64% YoY from -$542834.6 in Q1 2025, and down 134.96% on a QoQ basis from $2.7 million in Q3 2025.
Alvotech (ALVO) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Change in Accured Expenses data on file, last reported at -$948000.0 in Q1 2026.
- Quarterly Change in Accured Expenses rose 74.64% year-over-year to -$948000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (up 93.76% YoY) and the FY2023 annual result came in at $2.2 million, up 3758.93% from the prior year.
- Change in Accured Expenses eased to -$948000.0 in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $14.5 million in Q1 2024 to a low of -$25.0 million in Q3 2024.
- A 5-year average of -$992500.0 and a median of $482000.0 in 2022 frame the typical range for Change in Accured Expenses.
- The widest YoY moves for Change in Accured Expenses: up 2637.35% in 2024, down 714.92% in 2024.
- Tracing ALVO's Change in Accured Expenses over 5 years: stood at $493000.0 in 2022, then jumped by 159.63% to $1.3 million in 2023, then sank by 714.92% to -$7.9 million in 2024, then jumped by 134.46% to $2.7 million in 2025, then tumbled by 134.96% to -$948000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$948000.0 (Q1 2026), $2.7 million (Q3 2025), and -$179000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | -948,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -948,000.00 |
| Mar 31, 2026 | -948,000.00 |
| Sep 30, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | -179,000.00 |
| Jun 30, 2025 | -179,000.00 |
| Mar 31, 2025 | -3.74 Mn |
| Mar 31, 2025 | -3.74 Mn |
| Dec 31, 2024 | -7.87 Mn |
| Dec 31, 2024 | -7.87 Mn |
| Sep 30, 2024 | -25.04 Mn |
| Sep 30, 2024 | -25.04 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Mar 31, 2024 | 14.54 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Jun 30, 2023 | 471,000.00 |
| Jun 30, 2023 | 471,000.00 |